Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Motus Gi Holdings Inc (MOTS)

Motus Gi Holdings Inc (MOTS)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0001 unch (unch) 04/21/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0001 unch (unch) 09:30 ET
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.0001
Day High
0.0001
Open 0.0001
Previous Close 0.0001 0.0001
Volume 100 100
Avg Vol 3,070 3,070
Stochastic %K 50.00% 50.00%
Weighted Alpha -72.00 -72.00
5-Day Change unch (unch) unch (unch)
52-Week Range 0.0001 - 0.1880 0.0001 - 0.1880
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 1
  • Shares Outstanding, K 5,769
  • Annual Sales, $ 320 K
  • Annual Income, $ -12,870 K
  • EBIT $ -10 M
  • EBITDA $ -9 M
  • 60-Month Beta 0.92
  • Price/Sales 0.44
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -14.69
  • Most Recent Earnings $-0.88 on 05/14/24
  • Next Earnings Date 05/13/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Information Systems

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0001 unch
on 04/21/25
Period Open: 0.0001
0.0001 unch
on 04/21/25
unch (unch)
since 03/20/25
3-Month
0.0001 unch
on 04/21/25
Period Open: 0.0002
0.0002 -50.00%
on 02/26/25
-0.0001 (-50.00%)
since 01/21/25
52-Week
0.0001 unch
on 04/21/25
Period Open: 0.0758
0.1880 -99.95%
on 05/31/24
-0.0757 (-99.87%)
since 04/19/24

Most Recent Stories

More News
Motus GI Announces 1-FOR-20 Reverse Stock Split

FORT LAUDERDALE, Fla., July 25, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology...

MOTS : 0.0001 (unch)
Motus GI to Release Second Quarter Results and Provide a Business Update on August 11

FORT LAUDERDALE, Fla., July 21, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology...

MOTS : 0.0001 (unch)
Motus GI Announces Positive Topline Data From EU Study of the Pure-Vu System in Hard-to-Prepare Patients Presented at Digestive Disease Week 2022

– The Pure-Vu system improved the adequate cleansing rate more than 200% to 97.7% in patients with a history of poor bowel preparation FORT LAUDERDALE,...

MOTS : 0.0001 (unch)
Motus GI Reports First Quarter 2022 Financial Results and Provides Business Update

Pure-Vu EVS approved for use at 11 hospitals since product launch commenced in March 2022; with strong procedural volumes and significant positive feedback...

MOTS : 0.0001 (unch)
Motus GI to Release First Quarter Results and Provide a Business Update on May 12

FORT LAUDERDALE, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology...

MOTS : 0.0001 (unch)
Motus GI Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Received FDA clearance in February 2022 to market Pure-Vu EVS, an all new, next-generation system that has been deployed to multiple hospitals in the first...

MOTS : 0.0001 (unch)
Motus GI to Release Fourth Quarter and Full Year 2021 Results and Provide a Business Update on March 29

FORT LAUDERDALE, Fla., March 15, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology...

MOTS : 0.0001 (unch)
Motus GI to Participate in Two Upcoming Investor Conferences in March 2022

FORT LAUDERDALE, Fla., March 02, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology...

MOTS : 0.0001 (unch)
Motus GI Receives FDA Clearance to Market the Pure-Vu® EVS System

-All New Pure-Vu EVS offers rapid set-up, improved navigation and enhanced cleansing capabilities to support expanded clinical utilization -Scientific...

MOTS : 0.0001 (unch)
Motus GI Announces U.S. Patent For The Pure-Vu® System's Automatic Self-Purging Features

Expanding patent portfolio extends first-mover advantage in the colonoscopy procedure market, estimated at close to 55M global procedures per year...

MOTS : 0.0001 (unch)

Business Summary

Motus GI Holdings, Inc. is a medical technology company. It focuses on the development and commercialization of the Pure-Vu(R) System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company also...

See More

Key Turning Points

3rd Resistance Point 0.0001
2nd Resistance Point 0.0001
1st Resistance Point 0.0001
Last Price 0.0001
1st Support Level 0.0001
2nd Support Level 0.0001
3rd Support Level 0.0001

See More

52-Week High 0.1880
Fibonacci 61.8% 0.1162
Fibonacci 50% 0.0940
Fibonacci 38.2% 0.0719
Last Price 0.0001
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro